Amicus Therapeutics Inc (FOLD)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | PHARMACEUTICALS |
| SIC: | PHARMACEUTICAL PREPARATIONS |
| CEO: | Bradley L. Campbell |
| Employees: | 480 |
| Web site: | amicusrx.com |
|
3675 MARKET STREET, PHILADELPHIA, PA, 19104
(215) 921-7600
| |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Amicus Therapeutics, Inc. focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease. It also develops AT-GAA, a novel treatment paradigm for Pompe disease; enzyme replacement therapies for Pompe diseases.
Please log in first to see chart